Study EHR Risk Stratification Tools (NCT06995378)
Evaluation of Patient and Provider Facing EHR-embedded Risk Stratification Tools
🩺 Plain-English Summary (8th-Grade Level)
This study evaluates whether adding machine learning-based risk information to electronic health record (EHR) lab result messages helps older adults better understand their risk of developing diabetes and influences their emotional responses, quality of life, and healthcare use. Eligible participants are adults aged 65 years and older with a UCLA primary care provider and a hemoglobin A1c level in the range (5.7-6.0%). Participants are identified automatically at the time their lab results are processed and are randomly assigned to receive either standard lab result messages or modified messages that include a "very low risk" label generated by a machine learning model. All participants who are randomized are invited to complete two surveys: one shortly after their lab result is posted in MyChart and a follow-up survey approximately 30 days later. The study also uses de-identified EHR data to examine patterns of healthcare utilization and progression to diabetes. Provider comments related to lab result messaging will be analyzed to explore differences in response patterns between the two groups.
Who can join: Review the eligibility criteria below.
Location: UCLA Health System — Los Angeles, California
Age range: 65 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- UCLA Health System — Los Angeles, California
📞 Contact the Study Coordinator
Phone: (310) 267-5250
Email: katenguyen@mednet.ucla.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Prediabetes
- Randomized Trial of Exercise Promotion in Primary Care — Pasadena, California
- Monounsaturated Fatty Acid Supplementation for Overweight and Obese Individuals With Prediabetes — Boston, Massachusetts
- Pharmacists' Delivery of Education to Prevent Diabetes in the New Orleans Hospitality Industry — New Orleans, Louisiana
- Assessing Gut Microbiota Mediated Health Outcomes of Whole Wheat and Its Major Bioactive Components — Columbus, Ohio
- Behavioral Nudges for Diabetes Prevention (BEGIN) Trial in Primary Care — Chicago, Illinois
- The YMCA Healthy Lifestyle Program for Prediabetes — Port Huron, Michigan
Explore by condition: All Prediabetes clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.